Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $122.14-$186.12 |
Market Cap | $14.7B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $3.3B |
Revenue Growth (YoY) | 39.5% |
Gross Profit (12 Mos) | $2.1B |
Diluted EPS | $6.78 |
News
See moreYahoo Finance • 2 days ago
Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results
Yahoo Finance • 9 days ago
Neurocrine Biosciences Presents New Analysis Establishing Benchmark for Clinically Meaningful Change in Overall Health Reported by Patients with Tardive Dyskinesia
Yahoo Finance • 12 days ago
Neurocrine Biosciences (NBIX) Starts Phase 2 Alzheimer’s Trial
Yahoo Finance • 16 days ago
Oppenheimer updates its top 50 buy list, rotating away from big banks
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 6027 Edgewood Bend Court, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,500 |